Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)68

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)36

Views

Views
December 20241
January 20253
February 20258
March 202513
April 20253
May 20254
June 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Singapore11
Spain5
Brazil2
United Kingdom1
 

Top cities views

Views
Narón4
Dallas2
Buffalo1
Council Bluffs1
Mableton1
Melbourne1
Paulista1
Santa Maria1
Scranton1